24 related articles for article (PubMed ID: 16007196)
1. Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia.
Benbarche S; Lopez CK; Salataj E; Aid Z; Thirant C; Laiguillon MC; Lecourt S; Belloucif Y; Vaganay C; Antonini M; Hu J; da Silva Babinet A; Ndiaye-Lobry D; Pardieu B; Petit A; Puissant A; Chaumeil J; Mercher T; Lobry C
Sci Adv; 2022 Feb; 8(6):eabg9455. PubMed ID: 35138899
[TBL] [Abstract][Full Text] [Related]
2. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
3. Role of the β Common (βc) Family of Cytokines in Health and Disease.
Hercus TR; Kan WLT; Broughton SE; Tvorogov D; Ramshaw HS; Sandow JJ; Nero TL; Dhagat U; Thompson EJ; Shing KSCT; McKenzie DR; Wilson NJ; Owczarek CM; Vairo G; Nash AD; Tergaonkar V; Hughes T; Ekert PG; Samuel MS; Bonder CS; Grimbaldeston MA; Parker MW; Lopez AF
Cold Spring Harb Perspect Biol; 2018 Jun; 10(6):. PubMed ID: 28716883
[TBL] [Abstract][Full Text] [Related]
4. Activated Stat5 trafficking Via Endothelial Cell-derived Extracellular Vesicles Controls IL-3 Pro-angiogenic Paracrine Action.
Lombardo G; Dentelli P; Togliatto G; Rosso A; Gili M; Gallo S; Deregibus MC; Camussi G; Brizzi MF
Sci Rep; 2016 May; 6():25689. PubMed ID: 27157262
[TBL] [Abstract][Full Text] [Related]
5. Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.
Saulle E; Riccioni R; Coppola S; Parolini I; Diverio D; Riti V; Mariani G; Laufer S; Sargiacomo M; Testa U
Br J Haematol; 2009 May; 145(3):399-411. PubMed ID: 19245429
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9.
Yao JS; Zhai W; Young WL; Yang GY
Biochem Biophys Res Commun; 2006 Apr; 342(4):1396-404. PubMed ID: 16516857
[TBL] [Abstract][Full Text] [Related]
7. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
9. VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing.
Santos SC; Miguel C; Domingues I; Calado A; Zhu Z; Wu Y; Dias S
Exp Cell Res; 2007 May; 313(8):1561-74. PubMed ID: 17382929
[TBL] [Abstract][Full Text] [Related]
10. The interaction between KDR and interleukin-3 receptor (IL-3R) beta common modulates tumor neovascularization.
Dentelli P; Rosso A; Garbarino G; Calvi C; Lombard E; Di Stefano P; Defilippi P; Pegoraro L; Brizzi MF
Oncogene; 2005 Sep; 24(42):6394-405. PubMed ID: 16007196
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor receptors: expression and function in solid tumors.
Wey JS; Stoeltzing O; Ellis LM
Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
[TBL] [Abstract][Full Text] [Related]
12. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
